Birth characteristics and risk of neuroblastoma in young children

Kevin Y Urayama1, Julie Von Behren, Peggy Reynolds

  • 1Division of Epidemiology, School of Public Health, University of California, Berkeley, CA, USA.

Insights

Prenatal and perinatal factors influence neuroblastoma risk, with variations based on infant age. Hispanic and "other" race/ethnicity show reduced risk, while postterm delivery and cesarean birth increase it.

Area of Science:

  • Pediatric Oncology
  • Epidemiology
  • Perinatal Medicine

Background:

  • Neuroblastoma incidence peaks in infancy, suggesting critical prenatal or perinatal influences.
  • Understanding these early-life factors is crucial for identifying neuroblastoma etiology.
  • Population-based studies are essential for investigating risk factors in diverse groups.

Purpose of the Study:

  • To investigate the association between prenatal and perinatal factors and neuroblastoma risk.
  • To identify specific risk factors varying by age at diagnosis (infancy vs. 1-4 years).
  • To compare risk across different racial/ethnic groups.

Main Methods:

  • Population-based case-control study using California birth certificates (1988-1997).
  • 508 neuroblastoma cases (diagnosed <5 years) and matched controls.
  • Multivariate analyses to assess odds ratios (OR) and confidence intervals (CI) for various factors.

Main Results:

  • Reduced neuroblastoma risk observed in Hispanic and "other" race/ethnicity compared to non-Hispanic Whites (OR=0.57, 0.56).
  • Increased risk associated with postterm/high birth weight delivery in infants (OR=6.99).
  • Elevated risk linked to cesarean delivery in children aged 1-4 (OR=1.72); reduced risk with multiple previous pregnancies in infants (OR=0.39).

Conclusions:

  • Prenatal and perinatal factors demonstrate a significant association with neuroblastoma risk.
  • Etiologic factors appear to be specific to the age at neuroblastoma diagnosis.
  • Findings highlight the importance of considering delivery characteristics and maternal history in neuroblastoma research.

Related Concept Videos

The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the anterior...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...